
A Dubai shipment of apalutamide 60 mg tablets needs more than a trade licence, an invoice and customs paperwork: the importer must align federal medicine registration, local pharmaceutical licensing, product documents and shipment clearance. By the end, you will know which authority and licence apply, how to verify the registered presentation, what to request from an Indian supplier, and when an exceptional import route requires prior approval.
Key takeaways
- Use an EDE pharmaceutical facility licence, not only a Dubai trade licence.
- Confirm the exact apalutamide 60 mg presentation is registered in the UAE.
- Match manufacturer, exporter, batch and product details across shipment documents.
- Prepare the EDE import permit before Dubai Customs clearance.
Which UAE authority and licence must a Dubai importer use?
Commercial import and sale of apalutamide 60 mg in Dubai require federal pharmaceutical approval from the Emirates Drug Establishment (EDE). A Dubai trade licence, customs registration or ordinary trading-company licence does not authorise placing this prescription oncology medicine on the UAE market.
| Authority | Role | What it does not replace |
|---|---|---|
| Emirates Drug Establishment (EDE) | Registers the finished medicine, oversees pharmaceutical establishments and handles federal import requirements | Dubai Customs clearance and local facility permissions |
| Dubai Health Authority (DHA) | Regulates relevant healthcare facilities and activities within Dubai | EDE product registration or federal medicine-import approval |
| MOHAP | Formerly handled federal medicines functions now associated with EDE | Current EDE approval where federal pharmaceutical regulation applies |
The importer needs a UAE-licensed pharmaceutical establishment with an authorised activity for importing and distributing medicines, plus an approved pharmaceutical or medical warehouse suitable for prescription products. Confirm that the entity holds a pharmaceutical establishment licence UAE regulators recognise and an approved local marketing-authorisation holder or agent for the product.
Before dispatch, verify these permissions:
- EDE registration for the exact apalutamide product
- The establishment’s pharmaceutical import and distribution activity
- The warehouse licence and approved storage site
- Dubai Customs importer and broker arrangements
- EDE shipment or import approval and batch documents
Do not use MOHAP or DHA as substitutes for EDE approval. If the product is unregistered, import only through an exceptional route that EDE confirms, such as an eligible named-patient or compassionate-use application; do not treat that permission as ordinary commercial registration.
How do you confirm that the exact 60 mg presentation is registered?
A registration for apalutamide in another strength, pack size or dosage form does not authorise import of apalutamide 60 mg tablets. Confirm the exact finished product record with the Emirates Drug Establishment (EDE) and the UAE-appointed marketing-authorisation holder before ordering stock.
1. Request the EDE registration record or certificate and compare the registered proposed name with the name on the purchase order, artwork and invoice. Record the product’s registration number and status.
2. Match every presentation attribute: apalutamide 60 mg strength, tablet dosage form, number of tablets per pack, registered manufacturer and marketing-authorisation holder. A 60 mg bottle is not interchangeable with a 60 mg blister pack if the registered pack presentation differs.
3. Ask the marketing-authorisation holder to confirm that the intended UAE label and leaflet match the approved record, including the registered name, strength, contents, manufacturer and registration details. Do not print altered artwork and call it a commercial variation; a name, pack or leaflet change can require regulatory approval.
4. Confirm that the record permits ordinary commercial import and sale, rather than relying on a Dubai trade licence or customs registration. UAE pharmaceutical product registration is separate from importer licensing and warehouse approval.
If no matching EDE registration exists, stop the commercial shipment. Ask EDE and the UAE-licensed pharmaceutical establishment whether an exceptional unregistered medicine import UAE route applies, such as a named-patient or compassionate-use request, and identify who must submit it. Do not describe that approval as ordinary registration or distribute the product beyond its authorised purpose.
Which exporter and manufacturer documents must match the shipment?
A single mismatch can stop release even when the medicine is registered. Reconcile the exporter’s file before dispatch, not after the shipment reaches Dubai.
Collect these records:
- EDE import approval or shipment-related approval
- Commercial invoice
- Packing list
- Transport document
- Certificate of origin
- Certificate of analysis (CoA)
- Manufacturer’s GMP evidence, product certificate or batch-release document requested by the authority
Compare each record with the registered presentation:
| Document | Compare against | Hold the shipment if |
|---|---|---|
| Commercial invoice | Apalutamide, 60 mg tablets, manufacturer, batch, manufacturing and expiry dates, pack size | The description, quantity or manufacturer differs |
| Packing list | Carton count, pack size, batch number and expiry date | Cartons contain a different batch or presentation |
| Certificate of origin | Declared manufacturing country and manufacturer | The origin conflicts with the approved manufacturer or invoice |
| Certificate of analysis (CoA) | Apalutamide, 60 mg, tablet dosage form, manufacturer, batch number, manufacturing date and expiry date | The CoA covers another batch, strength or dosage form |
| Transport document | Consignee, shipper, carton quantity and shipment reference | The consignee or quantities cannot be reconciled |
| GMP or product document | Legal manufacturer, manufacturing site and product identity | The site or company name is not the registered one |
Check the pack size separately: a 30-tablet pack is not automatically authorised because a 120-tablet pack is registered. Ask the exporter to correct discrepancies before dispatch and retain the final matched set for the customs broker and health authority.
What must the approved pack, leaflet and warehouse controls show?
The approved artwork must match the UAE-registered presentation, not merely the manufacturer’s standard export pack. Check both Arabic and English labelling for the registered product name, apalutamide 60 mg strength, tablet dosage form, tablet count, batch number, expiry date, storage statement, manufacturer, marketing-authorisation holder and registration details.
- Compare the carton, blister or bottle, and leaflet against the approved product information.
- Confirm that Arabic and English text carry the same strength, directions, warnings, storage conditions and pack contents.
- Check that the leaflet identifies prescription status and includes the approved safety information.
- Retain the approved artwork version and review every printed change before release.
Changing a logo, pack size, wording, manufacturer detail or leaflet statement can alter the registered product information. Treat revised artwork as a potential variation requiring authority approval, not as a routine reprint.
Registration does not establish the selling price. Confirm the approved UAE price before ordinary commercial sale; an Indian export price, tender price or reference-country price is not automatically the lawful Dubai price.
Store apalutamide at 20–25°C, allowing only the stated 15–30°C excursions, with recorded temperature monitoring. Keep cartons in the original package to protect tablets from light and moisture, and investigate excursions before release.
Use documented hazardous drug handling controls for receiving, damaged packs, spills, returns and disposal. Train staff, restrict access, segregate damaged stock and maintain traceable incident and waste records. Confirm the current UAE prescription and handling classification with the relevant authority.
How should you prepare the import permit and Dubai Customs clearance?
Registration does not clear a shipment. For each consignment, match the EDE import approval or other required health-authority approval to the importer, product, quantity, batch and destination before dispatch.
1. Confirm the importer’s pharmaceutical warehouse licence, customs registration and authorised import activity. Dubai Customs does not replace EDE approval; a customs-ready shipment remains non-releasable if the medicine registration or federal approval is missing.
2. Prepare the clearance file with the EDE import approval, commercial invoice, packing list, certificate of origin, transport document and the product or batch records requested by EDE or your customs broker. Use the live EDE checklist for document authentication and validity rules.
3. Agree the HS classification for pharmaceutical products with the broker before invoicing. Record the confirmed code, accurate invoice value, currency, Incoterm, quantity, pack size, country of origin and manufacturer; an unexplained value or inconsistent origin can stop the electronic customs declaration.
4. Compare every field across the invoice, packing list, airway bill or bill of lading, certificate of origin and approval. Check the apalutamide strength, tablet presentation, batch number, expiry date and consignee name.
5. Submit the electronic customs declaration through the importer’s Dubai Customs arrangement, then answer any inspection or document query before release. Do not dispatch on an assumption that registration alone authorises import.
An India-to-UAE export partner such as Cordium Pharmaceuticals Pvt Ltd can assemble the exporter’s records, check them against the approval and reconcile discrepancies before the shipment leaves India. That review catches mismatched batch numbers, values and consignee details while correction is still possible.
Related products
![]() | Oncology Medicine Apnat Tablets – Apalutamide 60 mg for Prostate Cancer in Dubai, UAE Apnat Tablets contain apalutamide 60 mg, an oral prescription medicine used as part of the treatment of certain types of prostate cancer. |
![]() | Oncology Medicine Tamoxol Tablets 10 mg and 20 mg in UAE: Strengths, Uses and FAQs Tamoxol Tablets: Product Overview Tamoxol Tablets are associated with the search for tamoxifen-based medication. |
Frequently asked questions
Which UAE authority and licence must a Dubai importer use for apalutamide 60 mg?
Use Emirates Drug Establishment approval and a pharmaceutical facility licence covering commercial import and distribution. A Dubai trade licence or customs registration alone is not sufficient.
How can you confirm that apalutamide 60 mg is registered in the UAE?
Check the EDE registration for the exact product, strength, dosage form, manufacturer and pack presentation before ordering the shipment.
Which documents must the exporter and manufacturer provide?
Match the commercial invoice, packing list, certificate of analysis, certificate of pharmaceutical product, batch details and manufacturer information to the approved product and shipment.
What must the approved pack, leaflet and warehouse controls show?
Check the registered pack and leaflet, Arabic and English labelling where required, batch and expiry details, tamper evidence, storage conditions and documented temperature controls.
How should you prepare the import permit and Dubai Customs clearance?
Secure the EDE import permit, confirm consignee and product details, then submit consistent invoice, packing list, airway bill and regulatory documents for Dubai Customs clearance.








